NICE (UK National Institute for Clinical Excellence) refuses routine use of ACT (autologous cartilage transplantation)
This article was originally published in Clinica
Executive Summary
The UK National Health Service (NHS) will not offer autologous cartilage transplantation (ACT) for routine primary care treatment of articular cartilage defects of the knee. Guidance issued by the National Institute for Clinical Excellence (NICE) recommends that ACT should be performed only as part of a clinical trial or, in exceptional circumstances, at centres where clinical trials are taking place and other treatments have failed.